Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Schito

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
International Journal of Antimicrobial Agents|October 7, 2003
Why fosfomycin trometamol as first line therapy for uncomplicated UTI?G C Schito
International Journal of Antimicrobial Agents|January 4, 2001
Resistance patterns of lower respiratory tract pathogens in EuropeA Marchese, G C Schito
International Journal of Antimicrobial Agents|November 18, 2005
Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003)G C Schito, D Felmingham
Medecine Et Maladies Infectieuses|April 1, 2008
[Recent results of multinational studies on antibiotic resistance: should we have "PROTECTion" against these resistances?]A Marchese, G C Schito
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. The Italian Ceftibuten Study GroupG C Schito, G Nicoletti
Drugs|March 29, 2001
Role of global surveillance in combating bacterial resistanceA Marchese, G C Schito
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1973
[Presence of antibacterial substances in the urine and quantitative evaluation of bacteriuria]F Allevato, G C Schito
Drugs|January 1, 1995
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolonesG Molinari, G C Schito
Biochimica Et Biophysica Acta|May 25, 1971
Physicochemical properties of N4 coliphage protein ghostsA Pesce, G C Schito
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 2, 2001
The oxazolidinones as a new family of antimicrobial agentA Marchese, G C Schito
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
International Journal of Antimicrobial Agents|October 7, 2003
Why fosfomycin trometamol as first line therapy for uncomplicated UTI?G C Schito
International Journal of Antimicrobial Agents|January 4, 2001
Resistance patterns of lower respiratory tract pathogens in EuropeA Marchese, G C Schito
International Journal of Antimicrobial Agents|November 18, 2005
Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003)G C Schito, D Felmingham
Medecine Et Maladies Infectieuses|April 1, 2008
[Recent results of multinational studies on antibiotic resistance: should we have "PROTECTion" against these resistances?]A Marchese, G C Schito
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. The Italian Ceftibuten Study GroupG C Schito, G Nicoletti
Drugs|March 29, 2001
Role of global surveillance in combating bacterial resistanceA Marchese, G C Schito
Quaderni Sclavo Di Diagnostica Clinica E Di Laboratorio|December 1, 1973
[Presence of antibacterial substances in the urine and quantitative evaluation of bacteriuria]F Allevato, G C Schito
Drugs|January 1, 1995
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolonesG Molinari, G C Schito
Biochimica Et Biophysica Acta|May 25, 1971
Physicochemical properties of N4 coliphage protein ghostsA Pesce, G C Schito
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 2, 2001
The oxazolidinones as a new family of antimicrobial agentA Marchese, G C Schito
Pageof 17